HRES 803·Federal·house
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
In CommitteeFiled Oct 10, 2025
Sponsor: Rep. Rose, John W. [R-TN-6] (R)
Latest Action
Referred to the House Committee on Energy and Commerce.
Oct 10, 2025
Topics
Track this bill
Get real-time alerts when HRES 803 changes status, plus AI-powered summaries and stage predictions.
Sign up free